Home/ Supplements/ Probiotics/ ProBiotic Eight 65

ProBiotic Eight 65

product on market Capsule Vinco Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade
Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for ProBiotic Eight 65
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetable Capsule(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Proprietary Blend
227.5 mg

Other Ingredients

Microcrystalline Cellulose Hypromellose Fructooligosaccharides Silica Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement for adults and children twelve or more years of age, take one or two capsules per day, or as directed by a qualified healthcare professional.

Warnings & Precautions

Keep out of reach of children.

Tamper resistant. Do not purchase if seal is broken.

Formulation Notes

Vinco's ProBiotic Eight 65 contains a blend of premium cultures for human nutrition with 3% FOS. Prebiotic (FOS) is a bifidogenic factor that stimulates the growth of beneficial bifidobacteria.

8 strains/ 65 billion CFU

Dairy Free Gluten Free

No wheat, no gluten, no corn, no dairy, no soy, no yeast

Additional Information

Must keep refrigerated: Label claim of 65 billion is what the user can expect to receive by the last dose if refrigerated.

Store in a cool, dry place.

Professional formulation

Metadata

Product Details

UPC / SKU7 39930 27573 7
DSLD Entry Date2024-09-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandVinco
DSLD ID317884
Data Updated2026-04-11
Research

Research Evidence

691
Research Sources
52
Avg Quality
255
Clinical Trial
205
Meta Analysis
123
Rct
81
Systematic Review
18
Cochrane Review
2
Guideline
2
Regulatory Source
1
Other
1
Narrative Review
1
Openfda Safety
A Probiotics for preventing acute upper respiratory tract infections
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Probiotics for maintenance of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for induction of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Probiotics for treating eczema
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Probiotics for treating acute infectious diarrhoea
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Systematic Review International journal of molecular sciences 2022 PubMed DOI
A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Probiotics to prevent infantile colic
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
View all evidence for Probiotics →
Compare

Similar Products

View all Probiotics products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.